Recent Finacing
Recent Raise
Transcend Therapeutics, a New York biotech, develops short‑acting psychoactive compounds (lead TSND‑201 methylone) as adjunctive treatments for neuropsychiatric disorders and runs real‑world studies and clinical trials.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
